‘A Global Movement For More Democracy In Medicine’ – Formycon Chief Talks Biosimilars Strategy

Formycon CEO Stefan Glombitza Delves Into Detail On Recent Deals, Launches And Pipeline

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.